liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Plasma CXCL8 and MCP-1 as surrogate plasma biomarkers of latent tuberculosis infection among household contacts-A cross-sectional study
State Public Health Laboratory, Directorate of Public Health and Preventive Medicine, DMS Campus, Teynampet, Chennai, Tamil Nadu, India.
Department of Biotechnology, Infection and Inflammation, Central University of Tamil Nadu, Thiruvarur, India.
Laboratory Centre, Xiamen University Malaysia, Sepang, Selangor, Malaysia.
National Tuberculosis Elimination Programme, Chennai, Tamil Nadu, India.
Show others and affiliations
2023 (English)In: PLOS Global Public Health, E-ISSN 2767-3375, Vol. 3, no 11, article id e0002327Article in journal (Refereed) Published
Abstract [en]

Early detection of latent tuberculosis infection (LTBI) is critical to TB elimination in the current WHO vision of End Tuberculosis Strategy. The study investigates whether detecting plasma cytokines could aid in diagnosing LTBI across household contacts (HHCs) positive for IGRA, HHCs negative for IGRA, and healthy controls. The plasma cytokines were measured using a commercial Bio-Plex Pro Human Cytokine 17-plex assay. Increased plasma CXCL8 and decreased MCP-1, TNF-a, and IFN-? were associated with LTBI. Regression analysis showed that a combination of CXCL8 and MCP-1 increased the risk of LTBI among HHCs to 14-fold. Our study suggests that CXCL-8 and MCP-1 could serve as the surrogate biomarkers of LTBI, particularly in resource-limited settings. Further laboratory investigations are warranted before extrapolating CXCL8 and MCP-1 for their usefulness as surrogate biomarkers of LTBI in resource-limited settings.

Place, publisher, year, edition, pages
Public Library of Science (PLoS), 2023. Vol. 3, no 11, article id e0002327
National Category
Clinical Laboratory Medicine
Identifiers
URN: urn:nbn:se:liu:diva-202598DOI: 10.1371/journal.pgph.0002327ISI: 001418842400001PubMedID: 37992019Scopus ID: 2-s2.0-85182017803OAI: oai:DiVA.org:liu-202598DiVA, id: diva2:1852555
Available from: 2024-04-18 Created: 2024-04-18 Last updated: 2025-05-23

Open Access in DiVA

fulltext(1492 kB)159 downloads
File information
File name FULLTEXT01.pdfFile size 1492 kBChecksum SHA-512
3bc59738a7b3045c27230a6407bbcbb7225ea718cb77282190b6a724202a2315d42d33c3731663aff670a7c07f7a98b983ff015fcb765ce3d0c5cda43e2fb282
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Larsson, Marie

Search in DiVA

By author/editor
Larsson, Marie
By organisation
Faculty of Medicine and Health SciencesDivision of Molecular Medicine and Virology
In the same journal
PLOS Global Public Health
Clinical Laboratory Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 161 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 496 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf